Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment

The COVID-19 pandemic has significantly impacted the way of life worldwide and continues to bring high mortality rates to at-risk groups. Patients who develop severe COVID-19 pneumonia, often complicated with ARDS, are left with limited treatment options with no targeted therapy currently available....

全面介紹

書目詳細資料

發表在:	Pharmaceutics
Main Authors:	Dragan Primorac, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, Lucija Zenić, Miomir Knežević, Stephen Minger, Denis Polančec
格式:	Article
語言:	英语
出版:	MDPI AG 2021-09-01
主題:	COVID-19 mesenchymal stromal cells MSCs immunomodulation ARDS
在線閱讀:	https://www.mdpi.com/1999-4923/13/9/1481